메뉴 건너뛰기




Volumn 6, Issue 10, 2013, Pages 1011-1014

Combination of chemopreventive agents in nanoparticles for cancer prevention

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CELECOXIB; CHITOSAN; CURCUMIN; CYCLIC GMP; GENIPIN; GREEN TEA EXTRACT; LIPOSOME; NANOPARTICLE; POLOXAMER; PROTEIN MCL 1; SOLID LIPID NANOPARTICLE; SULFORAPHANE; VARDENAFIL;

EID: 84887927548     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0312     Document Type: Note
Times cited : (10)

References (26)
  • 1
    • 84858424089 scopus 로고    scopus 로고
    • Converting cancer therapies into cures: Lessons from infectious diseases
    • Glickman MS, Sawyers CL. Converting cancer therapies into cures: lessons from infectious diseases. Cell 2012;148:1089-98.
    • (2012) Cell , vol.148 , pp. 1089-1098
    • Glickman, M.S.1    Sawyers, C.L.2
  • 2
    • 84865480687 scopus 로고    scopus 로고
    • Nanotechnology-based combinational drug delivery: An emerging approach for cancer therapy
    • Parhi P, Mohanty C, Sahoo SK. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy. Drug Discov Today 2012;17:1044-52.
    • (2012) Drug Discov Today , vol.17 , pp. 1044-1052
    • Parhi, P.1    Mohanty, C.2    Sahoo, S.K.3
  • 4
    • 43049131769 scopus 로고    scopus 로고
    • Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
    • LoPiccolo J, Blumenthal GM, Bernstein WB, Dennis PA. Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist Updat 2008;11:32-50.
    • (2008) Drug Resist Updat , vol.11 , pp. 32-50
    • LoPiccolo, J.1    Blumenthal, G.M.2    Bernstein, W.B.3    Dennis, P.A.4
  • 5
    • 32944482677 scopus 로고    scopus 로고
    • Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
    • DOI 10.1200/JCO.2005.04.937
    • Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 2005;23:7794-803. (Pubitemid 46657376)
    • (2005) Journal of Clinical Oncology , vol.23 , Issue.31 , pp. 7794-7803
    • Gradishar, W.J.1    Tjulandin, S.2    Davidson, N.3    Shaw, H.4    Desai, N.5    Bhar, P.6    Hawkins, M.7    O'Shaughnessy, J.8
  • 6
    • 84885190174 scopus 로고    scopus 로고
    • New perspectives in nanomedicine
    • S0163-7258:00145-9
    • Thorley AJ, Tetley TD. New perspectives in nanomedicine. Pharmacol Ther 2013; S0163-7258:00145-9.
    • (2013) Pharmacol Ther
    • Thorley, A.J.1    Tetley, T.D.2
  • 7
    • 84855837427 scopus 로고    scopus 로고
    • Curcumin nanoformulations: A future nanomedicine for cancer
    • Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today 2012;17:71-80.
    • (2012) Drug Discov Today , vol.17 , pp. 71-80
    • Yallapu, M.M.1    Jaggi, M.2    Chauhan, S.C.3
  • 9
    • 78049442013 scopus 로고    scopus 로고
    • Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer
    • Nair HB, Sung B, Yadav VR, Kannappan R, Chaturvedi MM, Aggarwal BB. Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol 2010; 80:1833-43.
    • (2010) Biochem Pharmacol , vol.80 , pp. 1833-1843
    • Nair, H.B.1    Sung, B.2    Yadav, V.R.3    Kannappan, R.4    Chaturvedi, M.M.5    Aggarwal, B.B.6
  • 10
    • 84863115216 scopus 로고    scopus 로고
    • Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability
    • Camb
    • Hu B, Ting Y, Yang X, Tang W, Zeng X, Huang Q. Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability. Chem Commun (Camb) 2012;48:2421-3.
    • (2012) Chem Commun , vol.48 , pp. 2421-2423
    • Hu, B.1    Ting, Y.2    Yang, X.3    Tang, W.4    Zeng, X.5    Huang, Q.6
  • 11
    • 84887905558 scopus 로고    scopus 로고
    • A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates signi ficant suppression of pancreatic cancer neoplastic lesions
    • Grandhi BK, Thakkr A, Wang J, Prabhu S. A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates signi ficant suppression of pancreatic cancer neoplastic lesions. Cancer Prev Res 2013;6:1015-25.
    • (2013) Cancer Prev Res , vol.6 , pp. 1015-1025
    • Grandhi, B.K.1    Thakkr, A.2    Wang, J.3    Prabhu, S.4
  • 12
    • 57349171371 scopus 로고    scopus 로고
    • Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery
    • Muchow M, Maincent P, Muller RH. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm 2008;34:1394-405.
    • (2008) Drug Dev Ind Pharm , vol.34 , pp. 1394-1405
    • Muchow, M.1    Maincent, P.2    Muller, R.H.3
  • 13
    • 34250308874 scopus 로고    scopus 로고
    • Studies on oral absorption of stearic acid SLN by a novel fluorometric method
    • DOI 10.1016/j.colsurfb.2007.03.002, PII S0927776507001166
    • Yuan H, Chen J, Du YZ, Hu FQ, Zeng S, Zhao HL. Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf B Biointerfaces 2007;58:157-64. (Pubitemid 46921452)
    • (2007) Colloids and Surfaces B: Biointerfaces , vol.58 , Issue.2 , pp. 157-164
    • Yuan, H.1    Chen, J.2    Du, Y.-Z.3    Hu, F.-Q.4    Zeng, S.5    Zhao, H.-L.6
  • 14
    • 0031782519 scopus 로고    scopus 로고
    • Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats
    • DOI 10.1023/A:1011975120776
    • Bargoni A, Cavalli R, Caputo O, Fundaro A, Gasco MR, Zara GP. Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. Pharm Res 1998;15:745-50. (Pubitemid 28275652)
    • (1998) Pharmaceutical Research , vol.15 , Issue.5 , pp. 745-750
    • Bargoni, A.1    Cavalli, R.2    Caputo, O.3    Fundaro, A.4    Gasco, M.R.5    Zara, G.P.6
  • 16
    • 84862248921 scopus 로고    scopus 로고
    • Cancer cell signaling pathways targeted by spice-derived nutraceuticals
    • Sung B, Prasad S, Yadav VR, Aggarwal BB. Cancer cell signaling pathways targeted by spice-derived nutraceuticals. Nutr Cancer 2012;64:173-97.
    • (2012) Nutr Cancer , vol.64 , pp. 173-197
    • Sung, B.1    Prasad, S.2    Yadav, V.R.3    Aggarwal, B.B.4
  • 18
    • 84869783446 scopus 로고    scopus 로고
    • Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen
    • Sutaria D, Grandhi BK, Thakkar A, Wang J, Prabhu S. Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen. Int J Oncol 2012;41:2260-8.
    • (2012) Int J Oncol , vol.41 , pp. 2260-2268
    • Sutaria, D.1    Grandhi, B.K.2    Thakkar, A.3    Wang, J.4    Prabhu, S.5
  • 19
    • 84874740027 scopus 로고    scopus 로고
    • The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer
    • Thakkar A, Sutaria D, Grandhi BK, Wang J, Prabhu S. The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer. Oncol Rep 2013;29:1671-7.
    • (2013) Oncol Rep , vol.29 , pp. 1671-1677
    • Thakkar, A.1    Sutaria, D.2    Grandhi, B.K.3    Wang, J.4    Prabhu, S.5
  • 21
    • 51049115143 scopus 로고    scopus 로고
    • Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin
    • Lu G, Xiao H, You H, Lin Y, Jin H, Snagaski B, et al. Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin. Clin Cancer Res 2008;14:4981-8.
    • (2008) Clin Cancer Res , vol.14 , pp. 4981-4988
    • Lu, G.1    Xiao, H.2    You, H.3    Lin, Y.4    Jin, H.5    Snagaski, B.6
  • 22
    • 74049089011 scopus 로고    scopus 로고
    • Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells
    • Yang Z, Xiao H, Jin H, Koo PT, Tsang DJ, Yang CS. Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells. Int J Cancer 2010;126:852-63.
    • (2010) Int J Cancer , vol.126 , pp. 852-863
    • Yang, Z.1    Xiao, H.2    Jin, H.3    Koo, P.T.4    Tsang, D.J.5    Yang, C.S.6
  • 23
    • 84862646294 scopus 로고    scopus 로고
    • Chitosan-based drug nanocarriers: Where do we stand?
    • Garcia-Fuentes M, Alonso MJ. Chitosan-based drug nanocarriers: where do we stand? J Control Release 2012;161:496-504.
    • (2012) J Control Release , vol.161 , pp. 496-504
    • Garcia-Fuentes, M.1    Alonso, M.J.2
  • 24
    • 84872032765 scopus 로고    scopus 로고
    • Organ-specific exposure and response to sulforaphane, a key chemopreventive ingredient in broccoli: Implications for cancer prevention
    • Veeranki OL, Bhattacharya A, Marshall JR, Zhang Y. Organ-specific exposure and response to sulforaphane, a key chemopreventive ingredient in broccoli: implications for cancer prevention. Br J Nutr 2013;109:25-32.
    • (2013) Br J Nutr , vol.109 , pp. 25-32
    • Veeranki, O.L.1    Bhattacharya, A.2    Marshall, J.R.3    Zhang, Y.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.